of synaptic vesicles depends on the metabolism and position of mitochondria at the synapse 12 . Certain mitochondrial-interacting proteins such as Drp1 and Bcl-x L participate in synaptic strengthening or vesicle recovery after high-frequency firing 3, [12] [13] [14] . As high metabolic demand occurs during synaptic strengthening, a possible action of Bcl-x L is to increase the release or production of mitochondrial metabolites during synaptic plasticity.
We have now found that neurons overexpressing Bcl-x L have higher ATP levels, and cells in which endogenous Bcl-x L is depleted or inhibited have lower ATP levels. Despite the increase in the level of ATP, neurons overexpressing Bcl-x L use less oxygen, and Bcl-x L depletion increases the level of oxygen uptake. In addition to its outer membrane localization, we find Bcl-x L in the mitochondrial matrix by immuno-electron microscopy. Bcl-x L co-immunoprecipitates with the β-subunit of the F 1 F O ATP synthase and binds to the purified recombinant β-subunit of the F 1 ATP synthase. Exogenously applied Bcl-x L increases the level of F 1 F O ATPase activity, and Bcl-x L inhibition decreases the enzymatic rate. Bcl-x L deficiency decreases the capacity of F 1 F O -ATPase-containing submitochondrial vesicles to sequester H + ions, indicating that Bcl-x L depletion causes protons to leak following activation of the enzyme. By patch clamping F 1 F O -ATPase-containing vesicles exposed to ATP, we record an increased leak conductance when Bcl-x L is inhibited or depleted. We therefore suggest a model whereby Bcl-x L increases the efficiency of ATP synthesis by decreasing a proton leak within the F 1 F O ATPase, thus improving neuronal metabolism.
RESULTS

ATP levels are elevated in Bcl-x L -overexpressing neurons and decreased in Bcl-x L -depleted neurons
To determine the effect of Bcl-x L on ATP levels in neurons, the luminescence intensity of firefly luciferin-luciferase was measured in cultured hippocampal neurons expressing lentivirus constructs for green fluorescent protein (GFP)-tagged Bcl-x L or control GFP (ref. 15) . ATP levels in GFP-Bcl-x L -expressing cultures were approximately twice that of non-transduced or GFP-expressing controls ( Fig. 1a and Supplementary Fig. S1a ). Knockdown of Bcl-x L with an shRNAcarrying lentivirus but not with a scrambled control virus decreased ATP levels (Fig. 1b,c) , although the level of cell death was not significantly different at the time of the study ( Supplementary Fig. S1b ). To further examine the effect of endogenous Bcl-x L on ATP levels, Bcl-x L activity was pharmacologically inhibited by ABT-737, a mimetic of BH3-only proteins that binds to Bcl-x L (refs 14,16) . ATP levels were decreased in cultures exposed to ABT-737 (Fig. 1d) .
Measurements of luminescence in lysed cells cannot accurately indicate ongoing levels of ATP production in live neurons. Therefore, to measure ATP levels in live neurons (excluding glia), neurons were engineered to express luciferase by lentiviral transduction (Fig. 1d) . The application of luciferin led to an immediate rise in luminescence intensity ( Fig. 1e calibrated to known concentrations of ATP). Such calibrated light levels were significantly higher in GFP-Bcl-x Lexpressing neurons when compared with mito-GFP controls (Fig. 1f) .
Elevated ATP levels in the Bcl-x L -overexpressing cultures may be explained by an increase in the level of aeorobic glycolysis. To determine whether glycolysis is increased by Bcl-x L , lactate production was assessed by measuring lactate levels in the medium. The lactate level was significantly higher in controls when compared with the Bcl-x L -expressing neurons, indicating that Bcl-x L cells have a lower level of aerobic glycolytic activity than controls (Fig. 1g) . To further investigate the use of mitochondrial metabolism, cell viability was measured in a medium containing only mitochondrial substrates ( Supplementary Fig. S1c ). GFP-Bcl-x L -overexpressing cells had improved survival when compared with controls, indicating enhanced mitochondrial competence.
Bcl-x L decreases the level of mitochondrial oxygen uptake
Previous work described increased mitochondrial biomass in neurons overexpressing Bcl-x L (ref. 10 ; also see Supplementary Fig. S2 ). If increased mitochondrial biomass were solely responsible for increased ATP levels, then Bcl-x L -expressing cells would be expected to have increased oxygen uptake. To examine this, oxygen uptake was measured in single neurons in culture using a sensitive self-referencing oxygen electrode 17 ( Fig. 2a and Supplementary Fig. S3a,b) . Contrary to expectation, the oxygen flux of Bcl-x L -overexpressing neurons was lower than that of mito-GFP-transfected neurons (Fig. 2b) , indicating that Bcl-x L -overexpressing neurons couple ATP production more efficiently to oxygen uptake. Endogenous Bcl-x L has a similar effect because shRNA-mediated depletion (Fig. 2c,d ) or pharmacological inhibition of Bcl-x L (Fig. 2e ) activity increased oxygen flux by neurons. These data indicate that depletion or inhibition of Bcl-x L uncouples ATP production from oxygen uptake [18] [19] [20] . The higher ATP levels and lower levels of oxygen uptake of Bcl-x L -overexpressing neurons may, in theory, result from a quiescent state where ATP accumulates owing to decreased levels of electrical and synaptic activity. This is unlikely because Bcl-x L -overexpressing neurons have larger synapses and more spontaneous activity than controls 9, 10 . Therefore, we investigated whether Bcl-x L -overexpressing neurons have a greater but underutilized energetic capacity. Bcl-x Loverexpressing neurons increased their oxygen flux by approximately 90% over the basal level when cells were depolarized with high potassium (high K) conditions, a treatment known to stimulate neuronal electrical and synaptic activity 21, 22 (example shown in Fig. 2f ), whereas mito-GFP-expressing controls enhanced their flux by only 50%.
During oxidative phosphorylation, protons pumped out of the mitochondrial matrix re-enter the matrix by flux of H + across the inner mitochondrial membrane at the ATP synthase (productive flux) and by a H + leak (non-productive) 23 . A decrease in the non-productive leak increases the efficiency of ATP production. To determine whether Bcl-x L -overexpressing neurons have a different degree of non-productive leak across the inner membrane than controls during maximal activity, high K was rapidly washed out of the bath and oxygen uptake was measured in oligomycin, which inhibits H + flux associated with ATP production, but does not inhibit H + flux associated with the non-productive leak 24 . GFP-Bcl-x L cells had a higher ratio of productive oxygen flux to total oxygen flux when compared with mito-GFP-expressing controls, indicating that they use a higher percentage of the overall peak oxygen flux to make ATP (Fig. 2g ).
Bcl-x L enhances ATP synthesis during neuronal activity
Neurons may regulate metabolism during periods of increased activity. To study the role of Bcl-x L in such enhanced energy production, we stimulated neurons with high K conditions and measured the cytosolic ATP levels 5 min after stimulation had ceased. Remarkably, the levels of ATP were increased, indicating a requirement for enhanced energy production that outlasted the period of stimulation. Such an increase in ATP levels was completely prevented by pre-exposure for 5 min of the neurons to the Bcl-x L inhibitor ABT-737, indicating that Bcl-x L was specifically required for the stimulation-induced metabolic change (Fig. 2h) .
Bcl-x L is localized to the mitochondrial inner membrane
Most of the previous studies have defined a role for Bcl-x L in mitochondrial outer membranes as a regulator of cell death or in releasing metabolites from mitochondria [25] [26] [27] [28] [29] , but a few studies have also indicated a localization of the related anti-apoptotic proteins Bcl2 (refs 30,31) and Bcl-x L (Hardwick laboratory, unpublished data) to the inner membrane. To confirm and extend these findings, we checked for mitochondrial localization of Bcl-x L in the Bcl-x L -overexpressing hippocampal neurons and in control rodent brain using immunoelectron microscopy. Bcl-x L was localized to the outer membrane Bcl -x L -shRNA-expressing neuron cultures at 4 days after viral transduction. GAPDH serves as a loading control. (c) ATP levels as measured by firefly luciferin-luciferase luminescence intensity in control cultures or cultures expressing Bcl -x L shRNA or scrambled shRNA at 4 days after viral transduction. The luminescence intensity was normalized to the protein level in each individual well (N = 11 for each condition, representing two independent cultures; * P < 0.03). (d) ATP levels as measured by firefly luciferin-luciferase luminescence intensity in control cultures or cultures exposed for 12-18 h to ABT-737 (ABT) at the indicated concentrations. The luminescence intensity was normalized to the protein level in each individual well (N = 15 for each condition, * * P < 0.004 * * * P < 0.0001, three independent cultures). (e) Example image of a neuron expressing a CSCW2-luciferase lentiviral vector. Light is produced in response to the application of 1 mM luciferin. Shown are phase, luminescent and overlay images. In the pseudocolour images, blue is low luminescence and yellow is high luminescence. Scale bar, 20 µm. (f) Group data for the amount of ATP represented by the luminescence intensity per coverslip of living hippocampal neurons at 7 days after transfection with the indicated constructs. The light levels were normalized to the average of light levels in mito-GFP control cells. Living neurons were transfected with a CSCW2-luciferase-IG lentivirus vector and mito-GFP or GFP-Bcl-x L (N = 8 coverslips from at least three independent cultures for mito-GFP-expressing neurons, N = 10 coverslips from at least three independent cultures of GFP-Bcl-x L -expressing neurons, * P < 0.02). (g) Lactate levels in medium surrounding GFP-Bcl-x L -expressing neurons, compared with GFP-expressing controls, after 12 h in physiological (5 mM) glucose medium (one culture, N = 3 replicates for each condition * P < 0.02). For all panels error bars indicate s.e.m. Uncropped images of blots are shown in Supplementary Fig. S8 .
and inner membrane or matrix of mitochondria of GFP-Bcl-x Lexpressing neurons (Fig. 3a) and native brain mitochondria (Fig. 3b) . Furthermore, Bcl-x L (large gold beads) was co-localized at the inner membrane cristae with a known inner membrane cristae protein, manganese super oxide dismutase [32] [33] [34] (MnSOD; small gold beads; Fig. 3b ). Overall, Bcl-x L was localized about equally to inner membrane or matrix and to outer membrane (Fig. 3c) . Previous reports indicated localization of the anti-apoptotic protein Bcl2 to the mitochondrial inner membrane 30, 31, 35 or Bcl-x L to the same compartment as mitochondrial ATP synthase (Hardwick laboratory, unpublished data). To determine whether Bcl-x L was indeed localized within this compartment, submitochondrial vesicles of the inner membrane that are enriched in F 1 F O ATP synthase protein complexes (SMVs) and lack an outer membrane were prepared from whole rat brain 36, 37 . Bcl-x L was shown to be present by immunoblot in this purified sample (Supplementary Fig. S4 ). To further localize Bcl-x L within the inner membrane, the protein was co-immunoprecipitated with the ATP synthase complex β-subunit using either a specific antibody against Bcl-x L or a specific antibody against ATP synthase β-subunit (Fig. 3d) . To determine the exact binding site of Bcl-x L , recombinant Flag-and Myc-tagged proteins of the ATP synthase subunits α, β, c, d, δ, , γ and OSCP were immunoprecipitated from mammalian 293T cells using beads conjugated to anti-Flag antibody. Endogenous Bcl-x L co-immunoprecipitated only with α-and β-subunits (Fig. 3e ). The interaction with the β-subunit was blocked by the specific Bcl-x L inhibitor ABT-737, indicating that the β-subunit binds to Bcl-x L within the ABT-737-binding pocket (Fig. 3f) .
Recombinant Bcl-x L protein enhances the enzymatic rate of the F 1 F O ATPase
To determine whether Bcl-x L affects the enzymatic activity of F 1 F O ATPase, the rate of ATP hydrolysis was quantified in SMVs (refs 36,37) . Vesicles were treated with Triton X-100 to isolate the F 1 F O ATPase enzyme complex from the membrane. Activity of the F 1 F O ATPase was prevented by the ATP synthase inhibitor oligomycin, confirming the specificity of the reaction to the F 1 F O ATPase complex (Fig. 4a) . Bcl protein lacking the N terminus (Bcl-x N L ) also increased the rate of ATP hydrolysis ( Supplementary Fig. S5a ). To determine whether endogenous Bcl-x L contributed to the enzymatic rate, F 1 F O ATPase was exposed to ABT-737. Exposure to ABT-737 decreased the rate of ATP hydrolysis (Fig. 4b ), whereas dimethylsulphoxide carrier had no effect (Supplementary Fig. S5b ; N = 3).
The enzymatic activity of the F 1 F O ATPase was also measured in an ATP-regenerating assay where ATP concentration cannot be rate-limiting. Recombinant Bcl-x L protein significantly enhanced the enzymatic rate of the F 1 F O ATPase; inactive Bcl-x L protein had no effect (Fig. 4c) ; ABT-737 and another small-molecule inhibitor of Bcl-x L , obatoclax 38 , significantly decreased the enzymatic rate. The effect of Bcl-x L was mimicked by the application of a recombinant truncated Bcl-x L protein lacking the membranetargeting region (Bcl-x TM L ), indicating that specific membrane targeting is not necessary for this effect (Fig. 4c ). These studies indicate that endogenous or exogenously applied Bcl-x L enhances the enzymatic rate of the F 1 F O ATPase, and that the N and carboxy termini are not required for these effects. Furthermore, there was no change in the rate of ATP hydrolysis following exposure to membrane ionophores, nystatin or FCCP (N = 3 samples each, Supplementary Fig. S5c ), indicating that the channel-producing function of Bcl-x L is not responsible for the enhanced enzymatic rate of F 1 F O ATPase. Fig. 5a ). The addition of ATP to the control buffer in the absence of SMVs failed to change the ACMA fluorescence intensity (99.2 ± 1% control, N = 6), whereas the addition of ATP to SMVs resulted in a marked decrease in fluorescence intensity (Fig. 5b,c) . Attenuation of the maximum response to ATP occurred either following inhibition of H + ion import through the F O pump (oligomycin), or by leakage of H + out of the SMVs (FCCP). Attenuation also occurred in the presence of two different small-molecule Bcl-x L inhibitors, ABT-737 (ref. 16) or obatoclax 38 ( Fig. 5b,c) , consistent with the hypothesis that inhibition of endogenous Bcl-x L decreases the enzymatic rate or induces a H + leak within the SMV membrane.
Patch-clamp recordings of submitochondrial vesicles reveal a
Bcl-x L -sensitive membrane leak To more directly measure leak conductance, we developed a method to patch clamp the SMVs isolated from native rat brain. This method was based on our previous published methods in which we patch clamped similarly sized organelles (500-1,000 nm in diameter) either within living presynaptic terminals or isolated from brain, using pipettes with diameters of ∼180 nm (refs 3,40,41) . In an intracellular solution lacking ATP in both the bath and pipette, a giga-ohm seal was formed on the isolated SMVs; then currents were recorded while holding the membrane at different voltages between −150 mV and +150 mV.
The peak conductance was 600 pS on average. In some (Fig. 6a, left) but not all (Fig. 6c, left) recordings, gating between different levels of conductance was detected. As SMVs carry out ATP hydrolysis coupled to H + movement following the addition of ATP to the vesicles (see Fig. 5 ), and the F 1 portion of the F 1 F O ATPase faces the medium in the preparation 36 , we reasoned that the addition of ATP during recordings may produce a measurable current. In contrast, however, 0.5 mM ATP consistently resulted in decreased membrane conductance of the SMVs by approximately 70% (Fig. 6a,c middle, mean data shown in second bar in Fig. 6b,d ). The decrease in conductance most likely represents closure of channels and an increase in resistance caused by the effects of ATP on the membrane in series with the patched membrane.
The ATP effect indicates an ATP-responsive leak conductance associated with the F 1 F O ATPase. To determine whether the change in leak conductance occurred during ATP synthesis, succinate and ADP were added to mimic the conditions present during ATP synthesis. The decrease in membrane conductance was similar to that with ATP (N = 3, conductance decreased by 79±8%, P < 0.02, paired t -test), indicating that the leak conductance was equally sensitive to ADP or ATP.
To assess the role of Bcl-x L in determining mitochondrial membrane leak conductance, Bcl-x L activity was inhibited pharmacologically. Both ABT-737 and obatoclax increased the conductance in the SMV membranes when added in the presence of ATP (Fig. 6a-d) , although the leak was not affected by the addition of control buffer (0.1% dimethylsulphoxide, Supplementary Fig. S6a ) or the addition of ABT-737 or obatoclax in the absence of ATP (Fig. 6b,d) , indicating that the inhibitors themselves do not cause a leak.
To confirm the results obtained with pharmacological inhibition, knockdown of Bcl-x L using shRNA lentiviruses was carried out on cultured hippocampal neurons. Knockdown of Bcl-x L was confirmed with immunoblots ( Fig. 6e) . Consistent with the results for non-transduced controls, SMV patch-clamp recordings made from scrambled-shRNA-expressing cultures responded to ATP application with an approximately 80% decrease in peak conductance (measured from 0 pA; Fig. 6f,g ), whereas conductances from SMVs of Bcl-x LshRNA-transduced cultures had an approximately 50% decrease (Fig. 6g,h ). This indicates that endogenous Bcl-x L is required for full leak closure following ATP binding. Further studies showed that the Bcl-x L -regulated leak conductance in SMVs is different from the oligomycin-sensitive H + conductance and is pharmacologically distinct from that of the ANT or K ATP ( Supplementary Fig. S6b-g ). A non-selective proteinaceous pore that shunts H + ions away from H + -translocating activities found within the membrane portion of the F 1 F O ATPase protein complex is a reasonable candidate for the ATPand Bcl-x L -regulated leak conductance.
Bax-and Bak-independent cell survival depends on Bcl-x L -regulated metabolic changes
The anti-apoptotic function of Bcl-x L can exist independently of interaction with pro-apoptotic Bcl2 family members such as Bax and Bak 42 , but the mechanism of such protection is not fully understood. Glucose-free, galactose-containing media force mitochondrial metabolism. To address whether the metabolic function and the Baxand Bak-independent survival function of Bcl-x L overlapped, we studied the effects on ATP levels and cell survival of overexpression of Bcl-x L in Bax, Bak double-knockout (DKO) mouse embryonic fibroblasts (MEFs). ATP levels increased over time in Bcl-x L -expressing cells on galactose medium (Supplementary Fig. S7a ). The change in the medium decreased the level of survival of the MEFs; Bcl-x L overexpression enhanced the level of survival, indicating that increased mitochondrial ATP production by Bcl-x L may rescue cells from metabolic compromise in the absence of Bax or Bak (Supplementary Fig. S7b ).
DISCUSSION
Previous studies show that Bcl-x L increases mitochondrial biomass 9, 10 . Therefore, it was surprising to find that resting neurons expressing Bcl-x L use less oxygen but have higher ATP levels and decreased glycolysis levels. Stimulated Bcl-x L -expressing neurons use more of the total oxygen uptake for ATP production than stimulated controls. Moreover, Bcl-x L acutely increases the level of ATP production during neuronal stimulation, because ABT-737 completely prevents such an increase. These findings indicate that neuronal activity induces Bcl-x L -dependent changes in mitochondrial metabolism. In stimulated neurons, Bcl-x L expressed on endoplasmic reticulum membranes may influence the directed release of endoplasmic reticulum calcium towards mitochondrial calcium uptake mechanisms that may further enhance ATP synthesis 43 . Our evidence supports a Bcl-x L -and ATP-modulated H + leak in the inner mitochondrial membrane that decreases efficiency. An ATP-sensitive leak of H + measured with the H + indicator ACMA is re-activated by pharmacological inhibitors of Bcl-x L activity; patch-clamp recordings of SMVs reveal a large ion conductance attenuated by ATP, and re-activated by pharmacological inhibition of Bcl-x L activity or suppression of Bcl-x L expression. The leaky membrane of control SMVs may result from preparation of the vesicles without adenine nucleotides, but an adenine-nucleotide-deficient state may also exist under pathophysiological conditions such as ischaemia or neurodegenerative disorders. Re-introducing ATP or ADP rapidly closes the leak, indicating that ATP-or ADP-induced leak closure is an integral aspect of enzymatic function.
Although increased ATP synthase enzymatic activity will not directly increase efficiency, recombinant Bcl-x L protein and the Bcl-x L inhibitors regulate the enzymatic rate as measured by two assays ( Fig. 4) . These results raise the possibility that a change in position of certain proteins within the F 1 F O ATPase complex regulates enzymatic rate and leak closure. Bcl-x L has been found to act at the outer membrane [26] [27] [28] [29] . How Bcl-x L targets to the inner membrane is not known. Reports have located the related protein Bcl2 or Bcl-x L to the inner membrane 30, 44 in the same compartment as the β-subunit of the ATP synthase 31 (Chen and Hardwick, unpublished data), and have indicated that Bax requires the F 1 F O ATPase to initiate apoptosis 45 , and that oligomycin suppresses apoptosis 46 . The present study confirms and extends these findings, localizing Bcl-x L to the β-subunit by immuno-electron microscopy, by co-immunoprecipitation with the F 1 F O ATPase and by co-immunoprecipitation with purified mammalian α-and β-subunits. Binding of Bcl-x L to the β-subunit is reversed by ABT-737, indicating that the ABT-737-binding region is needed for binding to the β-subunit. Consistent with this, mutant recombinant Bcl-x L proteins lacking the BH4 domain (N terminus) or the membrane-targeting domain (C terminus) act as effectively as the full-length protein to increase the rate of ATP hydrolysis.
The protein responsible for the leak channel itself is as yet unidentified. Only a few of the proteins associated with F 1 F O ATPase have been characterized 37, 47 . Other ATP-sensitive candidate channels of the inner membrane include the ANT, mito-K ATP and members of the UCP family 20,48-52 . Although upregulation of UCP activity in brain enhances neuroprotection, levels of homologues of the UCPs in healthy brain are relatively low [53] [54] [55] . It is therefore likely that we have encountered a previously undescribed conductance within the F 1 F O ATPase.
The increase in ATP production by Bcl-x L -overexpressing healthy neurons was anticipated by studies showing an increase in the release of ATP and phosphocreatine in Bcl-x L -overexpressing non-neuronal cells undergoing death 7, 56 . Protection from cell death was attributed to enhanced release of ATP from mitochondria through Bcl-x L -regulated VDAC opening in the outer membrane. Our results do not preclude Bcl-x L activity in the outer membrane. In fact, it is likely that enhanced ATP production by the inner membrane F 1 F O ATP synthase complex requires the maintenance of VDAC in an open configuration to release the newly synthesized ATP into the cytosol.
Enhanced metabolic efficiency by Bcl-x L in neurons may produce resistance to death of tumour cells 57, 58 , and enhancement of cell survival shown here is independent of Bax and Bak (Supplementary Fig. S7 ). Some tumour cells manifest metabolic changes attributed to an increase in the level of aerobic glycolysis [59] [60] [61] . We show that healthy neurons use Bcl-x L to produce a different kind of metabolic efficiency. Nevertheless, the changes in metabolism produced by Bcl-x L may enhance resistance to pathological stressors including hypoxia and substrate deprivation and may maintain cytosolic ATP levels in the face of the increased energy demand provided by synaptic development, and long-or short-term changes in synaptic plasticity. 
METHODS
Methods
METHODS
Primary cultures of rat hippocampal neurons and transfections. Primary
rat hippocampal neurons were prepared as described previously 62, 63 and were transfected with 2.5 M calcium phosphate at DIV5 (5 days in vitro) with an efficiency of ∼1-5%. Neurons were transduced with a lentiviral construct at DIV4-8 and studied at DIV10-14 with an efficiency of near 100%.
Viral constructs.
Lentiviruses expressing Bcl-x L with an N-terminal GFP tag were used to transduce cultured hippocampal neurons, achieving almost 100% efficiency. Expression of GFP-Bcl-x L facilitates determination of protein levels by western blotting with an anti-GFP antibody (Anti-GFP Product #06-896 Upstate, 1:500). Full-length GFP-Bcl-x L was subcloned into a lentiviral vector c-FUW (ref. 64 ). Viral constructs were packaged in 293T cells by co-transfection with packaging plasmid δ8.9 and envelope plasmid VSVG.48, and at 60 h after transfection, virus-containing supernatant was collected and used to transduce cultured hippocampal neurons. Transduced neurons were studied at ∼7 days after transduction.
Lentiviral shRNA knockdown of Bcl-x L . The lentiviral plasmids expressing shRNAs were from Open Biosystems. The hairpin sequence against rat Bcl-x L was: 5 -CGGGCTCACTCTTCAGTCGGAATAGTGAAGCCACAGATGTATTCCGACT-GAAGAGTGAGCCCA-3 .
For a control, the scrambled, non-silencing shRNA sequence (Open Biosystems, catalogue number RHS4346) was used. Viruses were produced according to published methods 65 . The pGIPZ vector, containing either an shRNA sequence against Bcl-x L or the scrambled sequence was co-transfected with the packaging 8.9 and the vesicular stomatitis virus G protein vectors into HEK293T cells. The supernatant was purified after 72 h and added to the hippocampal cultures. The isolation of ATP F 1 F O ATPases was carried out 4 days after viral transduction of the neurons.
Luciferase assay for in vitro ATP and ADP measurements. Cellular ATP levels were measured following acute cell membrane lysis in a plate reader (Perkin-Elmer) in the presence of luciferin-luciferase (ApoSENSOR, Biovision). Luminescence values were normalized to protein concentration for each well (carried out using the Pierce BSA method).
Cytosolic ATP-luminescence intensity measured in situ. To continually monitor cytosolic ATP in intact cells, hippocampal neurons (E19, embryonic day 19) were transduced with a luciferase (firefly) lentiviral vector on DIV-4. The CSCW2-Luc-IRES-eGFP vectors were co-transfected into 293T cells with lentiviral packaging genome and envelope. Approximately 10 6 viral particles were used per 14 mm coverslip containing between 10 4 and 10 5 cells. Neurons were also co-transfected with plasmid DNA for either mito-GFP (control) or BCLxL-eGFP (efficiency of >50%) using magnetofection 66 (NeuroMag; OZ Biosciences) 9 . After 4-7 days of incubation, neurobasal growth media (Invitrogen) was replaced with warm ACSF (artificial cerebrospinal fluid) containing 120 mM NaCl, 3.1 mM KCl, 0.4 mM KH 2 PO 4 , 20 mM HEPES (pH 7.4), 5 mM NaHCO 3 , 1.2 mM NaSO 4 , 1.3 mM CaCl 2 , 5.5 mM glucose and 1 mM d-luciferin (Na salt; BD BioSciences). Light output from neurons was assessed in a custom-built, heated (37 • ) luminometer that includes a computer-controlled UNIBLITZ high-speed electronic shutter (Vincent Associates) and a photo-multiplier tube (R464; Hamamatsu Photonics). A concentration of 0.5 mM luciferin or greater generated maximum light output for a given coverslip. Once steady-state light output had been reached, mitochondrial ATP production was inhibited with oligomycin (10 mg ml −1 ). After 15 min, ATPdependent light levels were normalized for ATP by permeabilizing the neurons with a mock intracellular buffer 67 . Luciferase expression in neurons was verified by imaging single neurons for light output with a high-intensity CCD (charge-coupled device; C5405-50; Hamamatsu Photonics) mounted on an inverted microscope (Axiovert 135 TV; Carl Zeiss). A ×40 oil-immersion objective with a high numerical aperture (Fluar; Carl Zeiss) was used to ensure efficient light capture. Photons were integrated using custom-built acquisition software (BioCurrents Research Center).
Oxygen flux measurements. Oxygen uptake was measured in single neurons in culture using a sensitive oxygen electrode 17 . Oxygen flux was recorded using a 2-4 µm-diameter electrode at 5 µm from the cell that was moved with a displacement of 10 µm in the X -Y axes so that the oxygen-sensing electrode was positioned repeatedly closer to and farther from the cell. The current detected at two positions results in a differential current that can be translated into oxygen flux given the known oxygen concentration in the bath and the distance of the excursion of the electrode between the two points 17 ( Supplementary Fig. S3a,b ). The measured current associated with oxygen flux across the neuronal membrane was lower after treatment with oligomycin ( Supplementary Fig. S3b ). The measured current was further lowered by treatment of cells with the electron transport inhibitor antimycin A (Supplementary Fig. S3b ). For oxygen flux measurements carried out during neuronal activity, cells were perfused with an osmotically balanced extracellular solution containing a high KCl concentration (90 mM KCl, 64 mM NaCl, 2 mM MgCl 2 , 10 mM glucose, 10 mM HEPES, 2 mM CaCl 2 ; pH 7.4, 300 mOsm) for one minute followed by cessation of perfusion for one minute during which peak oxygen flux was measured. Cells were again perfused with normal extracellular buffer (KCl lowered to 2.5 mM) for one minute, followed by the addition of oligomycin (20 mg ml −1 ) to the bath. Oxygen flux was measured after cessation of perfusion and reaching a stable value for at least 5 min. F 1 F O ATPase vesicle preparation. Rodent whole brain without cerebellum was minced in isolation buffer (250 mM sucrose, 20 mM HEPES, at pH 7.2, 1 mM EDTA and BSA 0.5%). Tissue was homogenized in a Dounce homogenizer, then centrifuged at low speed (1300rcf-set tabletop to 4,000) to pellet nuclear material. Supernatant was centrifuged at high speed (13,000rcf) to pellet mitochondria and synaptosomes. Synaptosomes were disrupted with a nitrogen decompression chamber (Parr Instruments) at 1,200 psi for 10 min, followed by rapid decompression. Mitochondrial and burst synaptosomes were layered onto Ficoll gradients (10% and 7.5% Ficoll) and centrifuged in a Beckman ultracentrifuge at 32,500 rpm for 20 min. The pellet was washed and resuspended in isolation buffer (approximately 4-10 mg ml −1 protein), combined with an equal volume of digitonin (1% = 10 mg ml −1 isobuffer), incubated on ice for 15 min and centrifuged twice at 9,000g for 10 min. The pellet was resuspended in 200 µl of isolation buffer, and 2 µl of 10% Lubrol PX (C12E9; Calbiochem) was added, mixed and allowed to sit on ice for 15 min. The Lubrol-mitochondria mixture was layered onto isolation buffer and centrifuged at 39,000 rpm for 1 h. The final pellet was washed in isolation buffer and centrifuged at 13,000 rpm. ATP synthase enzyme activity assay. The ATPase activity was measured using the assay kit from Mitosciences (catalogue number MS541), according to the manufacturer's protocol and published methods 68 . Briefly, 5 mg F 1 F O ATPase (per well) was detergent-extracted and immunocaptured overnight within the 96-well plates. Inhibitors of Bcl-x L were added to the immobilized enzyme and incubated for 20 min before the addition of the reagent mix and measurement. The oxidation of NADH to NAD + results from a coupled reaction catalysed by pyruvate kinase and lactate dehydrogenase in the presence of phosphoenolpyruvate, which is dependent on ADP production by the ATPase in the presence of ATP. The change in fluorescence intensity as NADH is oxidized was measured as a decrease in absorbance at 340 nm using a PerkinElmer VICTOR3 multilabel plate reader.
Electrophysiology. F 1 F O ATPase vesicle recordings were made by forming a giga-ohm seal onto F 1 F O ATPase vesicles in intracellular solution (120 mM KCl, 8 mM NaCl, 0.5 mM EGTA and 10 mM HEPES, at pH 7.3) using an Axopatch 200B amplifier (Axon Instruments) at room temperature (22-25 • C). Recording electrodes were pulled from borosilicate glass capillaries (WPI) with a final resistance in the range of 80-120 MW. SMVs were visualized by phase-contrast microscopy with a Nikon or Zeiss inverted microscope. Signals were filtered at 5 kHz using the amplifier circuitry. Data were analysed using pClamp 10.0 software (Axon Instruments). All population data were expressed as mean ± s.e.m.. Membrane currents under different experimental conditions were assessed by measuring the peak membrane current (in pico-amperes)-the baseline current. The baseline current was defined as a nonspecific electrode leak current. All current measurements were adjusted for the holding voltage assuming a linear current-voltage relationship: the resulting conductances are expressed in picosiemens according to the equation G = V / I , where G is the conductance in picosiemens, V is the membrane holding voltage in millivolts and I is the peak membrane current in pico-amperes−baseline current in pico-amperes. Group data were quantified in terms of conductance.
ATP-driven quenching of ACMA. ACMA (9-amino-6-chloro-2-methoxyacridine) fluorescence quenching was measured according to previously published methods 69 . ACMA (2 µM; Sigma-Aldrich) was added to 5 µg isolated F 1 F O ATPase vesicles 47 , in the presence of ATP (1 mM), inhibitors of Bcl-x L , oligomycin or FCCP at concentrations described in the text (total volume of 100 µl). F 1 F O ATPase vesicle suspensions were excited at 410 nm, and emission was measured at 490 nm, using a PerkinElmer VICTOR3 multilabel plate reader.
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M E T H O D S
Electron microscopy. Hippocampal neuron cultures (DIV13-14) prepared from E18 embryonic rats were transduced with lentiviruses expressing GFP or GFP-Bcl-x L fusion protein to achieve gene expression in approximately 100% of the neurons 9 , and at 7 days post-infection, cultures were prepared for electron microscopy as previously described 9 .
Immuno-electron microscopy. Samples (either cultured cells or whole brain)
were fixed in 4% paraformaldehyde in 0.25 M HEPES for 1 h. Cultured cells were scraped and resuspended in 10% gelatin. Samples were rinsed in PBS, chilled and trimmed to smaller blocks then placed in 2.3 M sucrose overnight on a rotor at 4 • C. Brain tissue was cut into small pieces and placed in 2.3 M sucrose overnight on a rotor at 4 • C. Samples were then transferred to aluminium pins and frozen rapidly in liquid nitrogen. The frozen block was trimmed on a Leica Cryo-EMUC6 UltraCut and 65-75-nm-thick sections were collected using a previously published method 70 . The frozen sections were collected on a drop of sucrose, thawed and placed on a nickel formvar/carbon-coated grid and floated in a dish of PBS ready for immunolabelling. Grids were placed section side down on drops of 0.1 M ammonium chloride for 10 min to quench untreated aldehyde groups, then blocked on 1% fish-skin gelatin in PBS for 20 min. Single-labelled grids were incubated with rabbit anti-Bcl-x (Biocarta; 1:50) before rinsing and using 10 nm protein-A gold (UtrectUMC) for 30 min. Double-labelled grids used the primary rabbit anti-Bcl-x antibody with 10 nm protein-A gold followed by a primary mouse anti-mSod2 (Abnova 1:150) bridged using rabbit anti-mouse (Jackson 1:150) and 5 nm protein-A gold. All grids were rinsed in PBS, fixed using 1% gluteraldehyde for 5 min, rinsed and transferred to a uranyl acetate/methylcellulose drop for 10 min. Samples were viewed with a FEI Tencai Biotwin TEM at 80 kV. Images were taken using a Morada CCD and iTEM (Olympus) software.
Immunoprecipitation and western blot analysis. Cell lysate was incubated with 2 µg rabbit anti-Bcl-x L (54H6, Cell Signaling) and mouse anti-β-subunit (Mitosciences) antibodies in RIPA (radioimmunoprecipitation assay) buffer overnight at 4 • C with gentle rocking. Protein-G Sepharose beads (Sigma-Aldrich) were added and incubated overnight at 4 • C. Following three washes with the lysis buffer, the bound proteins were eluted from the beads with 2× Laemmli sample buffer. The immunoprecipitated samples were analysed by western blotting. For the Bcl-x L -synthase interaction study, the human open reading frame constructs for α, β, b, c, δ, d, , γ and OSCP ATP-synthase subunits, tagged with Myc and DDK (Flag), from Origene Technologies, were expressed in 293T cells and purified, using the EZview Red Anti-FLAG M2 Affinity Gel (Sigma), according to the manufacturer's protocol. The expression was verified and the binding of Bcl-x L to individual subunits was assessed by immunoblot analysis, using the mouse anti-Myc and rabbit anti-Bcl-x L antibodies (Cell Signaling), respectively.
Western blotting for mitochondrial protein was carried out using the following antibodies: rabbit anti-human Bcl-x L (A.G.Scientific, 1:1,000), anti-GFP antibody (ab290, Abcam, 1:1,000), rabbit anti-Drp1 (sc-32898, Santa Cruz, 1:1,000), rabbit anti-VDAC (#4866, Cell Signaling, 1:1,000), mouse anti-GAPDH, (sc-32233, Santa Cruz, 1:1,000), rabbit anti-ANT (sc-11433, Santa Cruz, 1:1,000), rabbit anti-PGC1 α, (#2178, Cell signalling, 1:1,000) and mouse anti-COXIV, (ab14744, abcam, 1:1,000).
Lactate measurements. Lactate was measured by enzyme-controlled fluorometric assay for NADPH-NADP conversion, following a previously published method 71 , using a CMA600 analyser (CMA; Microdialysis).
Statistical analysis. For comparisons involving two groups, paired or unpaired Student's t -tests (two-tailed) were used. In all figures, * = P < 0.05, * * = P < 0.01 and * * * = P < 0.001 denote significance level, and exact P values are provided in the figure legends.
Figure S1 a. ATP levels for different densities of neuron plating; low (n=12 wells for each condition), medium (n=4 wells each condition), mediumhigh (n=4 wells each condition) and high (n=3 wells each condition); experiments were from two independent cultures (***p< 0.0001 for GFP-Bcl-x L compared to control or GFP). Figure S6 a. Example of SMV patch recording before and after 0.1% DMSO. b. Example SMV recordings before and after ATP, then after oligomycin (5mg/ ml final). c. Group data for ATP-exposed SMV patch recordings before and after the addition of oligomycin (N=13 separate SMV recordings before and after oligomycin, **p<0.01, paired t test). Shown is the mean membrane conductance in both conditions after baseline leak subtraction. Because the effect of oligomycin is not occluded by pre-treatment with ATP, the data indicate that the ATP-sensitive conductance in SMVs is different from the oligomycin-sensitive proton conductance. d. Group data for SMV patch recordings before and after the addition of oligomycin, then ATP. Shown is the membrane conductance after baseline leak subtraction (N=7 recordings; *p<0.02). Note that the oligomycin-sensitive conductance is not present in the absence of ATP. e. Group data for ATP-exposed SMV patch recordings before and after the addition of Bongkrekic acid (BA; 10µM final), a membrane permeable inhibitor of ANT. Shown is the membrane conductance in both conditions after baseline leak subtraction (N=6 recordings). The data indicate that the ATP-regulated leak conductance is pharmacologically distinct from that of ANT. f. Group data for SMV patch recordings indicate that ATP is effective after the application of BA (N=6 before and after BA; N=3 to which ATP was added. g. Another conductance of the inner membrane that is sensitive to ATP is that of K ATP . A known inhibitor of K ATP channels, glibenclamide (1µM), had no effect on the conductance of the patches (N=3), suggesting that K ATP was also not responsible for the ATP-sensitive conductance in the g Figure S7 a. ATP levels measured by luminescence of firefly luciferase in Bax-/-;Bak-/-MEFs expressing the indicated constructs measured at 0, 5, 10hrs after change to galactose-containing, glucose-free medium (N=6 wells; *p < 0.05; experiments confirmed by two independent experiments). For each time point, measurements are normalized to the average of the control data. b. Cell survival measured at 5 and 24hrs after switching to galactose-containing, glucose-free medium. MEFs are expressing the indicated constructs (N=7 wells for each condition; **p < 0.01, ***p < 0.001; experiments confirmed by two independent experiments). For all panels error bars indicate SEM. 
